HomeOwner SearchCategory Search
Visit USCOAssay and Drug Development Technologies [Published: 2012-03-19 to 2013-02-21. Issues: vol. 11, no. 2, March 2013 to vol. 11, no. 1, January/February 2013]
Serial Registration
Copyright Title
Assay and Drug Development Technologies [Published: 2012-03-19 to 2013-02-21. Issues: vol. 11, no. 2, March 2013 to vol. 11, no. 1, January/February 2013]
Status
Published
on 22 May 2013
Year of Creation
2012
Copyright Claimant
Mary Ann Liebert, Inc
Registration Number
TX0007683570
on 22 May 2013Copyright Summary
The U.S. Copyright record (Registration Number: TX0007683570) dated 22 May 2013, pertains to an electronic file (eService) titled "Assay and Drug Development Technologies [Published: 2012-03-19 to 2013-02-21. Issues: vol. 11, no. 2, March 2013 to vol. 11, no. 1, January/February 2013]" created in 2012. The copyright holder is Mary Ann Liebert, Inc, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Mary Ann Liebert, Inc.
Application Details
Registration Number
TX0007683570
Registration Date
5/22/2013
Year of Creation
2012
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Mary Ann Liebert, Inc
First Publication Nation
United States
ISSN
1540-658X
Notes
Copyright Local Holdings: vol. 11, no. 1, January/February 2013 Pub. 2013-02-21 Reg. 2013-03-28 TX0007683570 KFOMvol. 11, no. 2, March 2013 Pub. 2012-03-19 Reg. 2013-03-28 TX0007683570 KFOM
Statements
Application Title Statement: Assay and Drug Development Technologies
Author Statement: Mary Ann Liebert, Inc employer for hire Authorship: collective work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.